International journal of surgery (London, England) · 2025
Unveiling metabolic pathway dysregulation in the malignant transformation of polyps to colorectal cancer: a single-cell analysis of epithelial cell trajectories.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hu Hui, Wu Jianhong, Lu Yanjun
Аннотация
BACKGROUND: Although metabolic reprogramming in colorectal cancer (CRC) has been studied, the changes in metabolic pathways and cellular communication from a healthy colon to precancerous adenoma and CRC remain poorly understood.
MATERIALS AND METHODS: Here, we utilized single-cell transcriptome data including normal, polyp, and tumor colon tissues to construct the epithelial cell differentiation trajectory during CRC progression. We scored pathway and lactylation activities using AUCell to analyze changes in CRC progression and the trajectory. We explored the cell communication between epithelial cells and other stromal cells during the process from polyps to CRC through cell communication analysis. Based on the transcription factor-gene-pathway regulatory network analysis, potential regulatory mechanisms were inferred.
RESULTS: We demonstrated that epithelial cell subpopulations dominate the malignant transformation process of CRC. The malignant trajectory of epithelial cell is accompanied by significant dysregulation of fatty acid and bile acid metabolism pathways, which may contribute to early CRC development. Additionally, this trajectory was associated with increased stemness, metastatic potential, and lactylation activity. The communication between myofibroblasts/endothelial and enterocytes subpopulations was established in the early CRC stages. Continuously altered genes (RUNX1, SOX4 STAT3, FOXO1) during CRC progression were closely related to metabolic regulations. Finally, seven dynamically changed lactylation-associated genes (HNRNPA1, PRPF6, PTMA, CALD1, FAM50A, RPL29, and RPL5) during CRC malignant transformation were identified as potential targets for metabolic intervention in CRC, highlighting a lactylation-related TF-gene-pathway regulatory network driving metabolic reprogramming.
CONCLUSION: This study elucidates the malignant evolution of epithelial cells, along with changes in metabolic pathway activity and key regulators, jointly promote CRC development. This research provides new insights into early CRC detection from the perspective of metabolic reprogramming, while nominating candidate targets worthy of further investigation for precise treatment strategies.
MATERIALS AND METHODS: Here, we utilized single-cell transcriptome data including normal, polyp, and tumor colon tissues to construct the epithelial cell differentiation trajectory during CRC progression. We scored pathway and lactylation activities using AUCell to analyze changes in CRC progression and the trajectory. We explored the cell communication between epithelial cells and other stromal cells during the process from polyps to CRC through cell communication analysis. Based on the transcription factor-gene-pathway regulatory network analysis, potential regulatory mechanisms were inferred.
RESULTS: We demonstrated that epithelial cell subpopulations dominate the malignant transformation process of CRC. The malignant trajectory of epithelial cell is accompanied by significant dysregulation of fatty acid and bile acid metabolism pathways, which may contribute to early CRC development. Additionally, this trajectory was associated with increased stemness, metastatic potential, and lactylation activity. The communication between myofibroblasts/endothelial and enterocytes subpopulations was established in the early CRC stages. Continuously altered genes (RUNX1, SOX4 STAT3, FOXO1) during CRC progression were closely related to metabolic regulations. Finally, seven dynamically changed lactylation-associated genes (HNRNPA1, PRPF6, PTMA, CALD1, FAM50A, RPL29, and RPL5) during CRC malignant transformation were identified as potential targets for metabolic intervention in CRC, highlighting a lactylation-related TF-gene-pathway regulatory network driving metabolic reprogramming.
CONCLUSION: This study elucidates the malignant evolution of epithelial cells, along with changes in metabolic pathway activity and key regulators, jointly promote CRC development. This research provides new insights into early CRC detection from the perspective of metabolic reprogramming, while nominating candidate targets worthy of further investigation for precise treatment strategies.